Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 11/2006

01.11.2006 | Editorial

124I in PET imaging: impact on quantification, radiopharmaceutical development and distribution

verfasst von: Andreas Bockisch, Lutz Freudenberg, Sandra Rosenbaum, Walter Jentzen

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Excerpt

This is an exciting time for nuclear medicine. For various reasons, increasing attention is being paid to the interesting field of molecular imaging, which has always essentially been the focus of nuclear medicine. …
Literatur
1.
Zurück zum Zitat Knust EJ, Dutschka K, Weinreich R. Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets. Appl Radiat Isot 2000;52:181–4PubMedCrossRef Knust EJ, Dutschka K, Weinreich R. Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets. Appl Radiat Isot 2000;52:181–4PubMedCrossRef
2.
Zurück zum Zitat Freudenberg LS, Antoch G, Jentzen W, Pink R, Knust J, Gorges R, et al. Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004;14:2092–8PubMedCrossRef Freudenberg LS, Antoch G, Jentzen W, Pink R, Knust J, Gorges R, et al. Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004;14:2092–8PubMedCrossRef
3.
Zurück zum Zitat Dingli D, Kemp BJ, O’Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of nis gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2005;19:1–8 Dingli D, Kemp BJ, O’Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of nis gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2005;19:1–8
4.
Zurück zum Zitat Eschmann SM, Reischl G, Bilger K, Kupferschlager J, Thelen MH, Dohmen BM, et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders bymeans of iodine-124 and PET. Eur J Nucl Med Mol Imaging 2002;29:760–7PubMedCrossRef Eschmann SM, Reischl G, Bilger K, Kupferschlager J, Thelen MH, Dohmen BM, et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders bymeans of iodine-124 and PET. Eur J Nucl Med Mol Imaging 2002;29:760–7PubMedCrossRef
5.
Zurück zum Zitat Herzog H, Tellman L, Qaim SM, Spellerberg S, Schmid A, Coenen HH. PET quantitation and imaging of the non-pure positron-emitting iodine isotope 124I. Appl Radiat Isot 2002;56:673–9PubMedCrossRef Herzog H, Tellman L, Qaim SM, Spellerberg S, Schmid A, Coenen HH. PET quantitation and imaging of the non-pure positron-emitting iodine isotope 124I. Appl Radiat Isot 2002;56:673–9PubMedCrossRef
Metadaten
Titel
124I in PET imaging: impact on quantification, radiopharmaceutical development and distribution
verfasst von
Andreas Bockisch
Lutz Freudenberg
Sandra Rosenbaum
Walter Jentzen
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2006
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-006-0208-1

Weitere Artikel der Ausgabe 11/2006

European Journal of Nuclear Medicine and Molecular Imaging 11/2006 Zur Ausgabe